Artificial Intelligence enhances breast cancer screening
Artificial intelligence offers radiologists smart support in breast cancer screening
In breast cancer screening programs, such as the one running in the Netherlands, a high volume of mammography data is acquired. Radiologists have to evaluate hundreds of images every day with precision and often under time pressure. Artificial intelligence (AI) offers radiologists smart support: “It’s like having an additional colleague at the press of a button,” says radiologist Ritse Mann of Radboud University Medical Center, Nijmegen, the Netherlands.
Case score
AI-driven case scoring holds great potential
The performance matches that of a good radiologist.
Ritse Mann, MD, PhD, head of breast imaging, Radboud University Medical Center, Nijmegen, the Netherlands.
A second opinion at the press of a button
AI speeds up tomosynthesis evaluation
Artificial intelligence from the patient’s perspective
More information
[1] Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, Helbich T, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: Comparison with 101 radiologists. J Natl Cancer Inst. 2019 Sep;111(9): 916–922. https://doi.org/10.1093/jnci/djy222
Rodriguez-Ruiz A, Krupinski E, Mordang J, Schilling K, Heywang-Kobrunner S, Sechopoulos I, et al. Detection of breast cancer using mammography: Impact of an Artificial Intelligence support system. Radiology. 2019 Feb;290(2), 305-314. https://doi.org/10.1148/radiol.2018181371
Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Teuwen J, Broeders M, Gennaro G, Clauser P, et al. Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study. Eur Radiol. 2019 Sep;29(9):4825-4832. https://doi.org/10.1007/s00330-019-06186-9
- The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. “Powered by AI” and “Interactive decision support” is optional and powered by TransparaTM, ScreenPoint Medical. The product names and/or brands referred to are the property of their respective trademark holders. syngo.via can be used as a standalone device or together with a variety of syngo.via based software options, which are medical devices in their own right. syngo.via and the syngo.via based software options are not commercially available in all countries. Their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.